Patents by Inventor Christoph Seidel

Christoph Seidel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6214549
    Abstract: The invention concerns a method of detecting a substance to be analyzed in a sample by contacting the sample with a probe which contains nucleobases and two or more non-nucleosidic marker-promoting groups in conditions in which the substance to be analyzed binds indirectly or directly to the probe. The method enables the binding product to be detected. The probe is preferably branched.
    Type: Grant
    Filed: September 10, 1998
    Date of Patent: April 10, 2001
    Assignee: Roche Diagnostics GmbH
    Inventors: Kurt Weindel, Christoph Seidel, Gerhard Lassonczyk
  • Patent number: 6210901
    Abstract: The invention relates to derivatives of hepatitis C virus amino acid sequences. These derivatives can be used to screen samples, such as blood, to determine if antibodies to hepatitis C virus are present.
    Type: Grant
    Filed: July 31, 1996
    Date of Patent: April 3, 2001
    Assignee: Roche Diagnostics GmbH
    Inventors: Christoph Seidel, Rupert Herrmann, Eva Hoess, Hans-Georg Batz
  • Patent number: 6183949
    Abstract: Novel HCV peptide antigens are described representing partial sequences of the C-100-3 and env/core with C-regions. These peptide antigens are suitable for the determination of HCV antibodies as immunogens for the production of antibodies against HCV and as vaccines for the production of vaccines against HCV.
    Type: Grant
    Filed: February 21, 1996
    Date of Patent: February 6, 2001
    Assignee: Roche Diagnostics GmbH
    Inventors: Christoph Seidel, Gertraud Ehrlich-Weinreich, Hubert Bayer, Ursula H Wienhues, Günther Gerhard Jung, Hans Georg Ihlenfeldt
  • Patent number: 6153393
    Abstract: The invention concerns the use of peptides which are comprised essentially of D-amino acids to eliminate interference in diagnostic methods, a method for eliminating interference in diagnostic methods by peptides which are comprised essentially of D-amino acids as well as a reagent that eliminates interference containing at least one peptide which is comprised essentially of D-amino acids.
    Type: Grant
    Filed: December 11, 1998
    Date of Patent: November 28, 2000
    Assignee: Roche Diagnostics GmbH
    Inventors: Christoph Seidel, Helmut Lenz, Johann Karl, Beatus Ofenloch-Hahnle, Ursula Klause, Elke Faatz
  • Patent number: 6096319
    Abstract: The present invention concerns a polypeptide which is composed of the amino acids 1207.+-.10 to 1488.+-.10 of a hepatitis C virus and of less than 20 foreign amino acids and the use of this polypeptide as an antigen in an immunological test.
    Type: Grant
    Filed: August 7, 1995
    Date of Patent: August 1, 2000
    Assignee: Roche Diagnostics GmbH
    Inventors: Christoph Seidel, Ursula-Henrike Wienhues, Urban Schmitt, Manfred Motz, Michael Wiedmann, Barbara Upmeier, Erwin Soutschek
  • Patent number: 5958783
    Abstract: The present invention concerns new metal complexes with a charged linker and their use as luminescent marker groups in an immunoassay.
    Type: Grant
    Filed: June 20, 1996
    Date of Patent: September 28, 1999
    Assignee: Roche Diagnostics GmbH
    Inventors: Hans-Peter Josel, Eva Hoss, Beatus Ofenloch-Hahnle, Christoph Seidel, Barbara Upmeier, Ursula-Henrike Wienhues
  • Patent number: 5846738
    Abstract: A conjugate of at least two binding sites that bind specifically to the analyte-specific binding region of the receptor that is used for detection in a test, wherein the binding sites are linked by at least one soluble carrier substance and the conjugate is a product of a synthetic or recombinant production, dissolved in an aqueous solution in an exactly known amount is particularly suitable as a stable calibrator in a test for the detection of an analyte.
    Type: Grant
    Filed: December 12, 1996
    Date of Patent: December 8, 1998
    Assignee: Boehringer Mannheim GmbH
    Inventors: Christoph Seidel, Peter Bialk, Herbert Von der Eltz
  • Patent number: 5804371
    Abstract: The invention concerns a process for the production of hapten-labelled peptides which is characterized in that (a) a peptide with the desired amino acid sequence is synthesized on a solid phase from amino acid derivatives whose reactive side groups are blocked by protecting groups wherein the protecting groups on primary amino side groups are selected in such a way that, if desired, they can be selectively cleaved off, (b) protecting groups are cleaved to form at least one free primary amino group, (c) a hapten-active ester derivative is coupled to the at least one free primary amino group of the peptide and (d) if desired protecting groups that still remain are cleaved off, the hapten being selected from the group comprising sterols, bile acids, sexual hormones, corticoids, cardenolides, cardenolide-glycosides, bufadienolides, steroid-sapogenines and steroid alkaloids.
    Type: Grant
    Filed: June 13, 1996
    Date of Patent: September 8, 1998
    Assignee: Boehringer Mannheim GmbH
    Inventors: Eva Hoss, Christoph Seidel, Ursula-Henrike Wienhues, Elke Faatz, Urban Schmitt
  • Patent number: 5688659
    Abstract: SLO peptide antigens are described. These peptide antigens are suitable for the determination of SLO antibodies, as immunogens for the production of antibodies against SLO and as vaccines for the production of vaccines against SLO.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 18, 1997
    Assignee: Boehringer Mannheim GmbH
    Inventors: Christoph Seidel, Geoffrey Burns, Wolf-Dieter Engel
  • Patent number: 5674676
    Abstract: New HCV peptide antigens are described. These peptide antigens are suitable for the determination of HCV antibodies as immunogens for the preparation of antibodies to HCV and as immunogens for the preparation of vaccines to HCV.
    Type: Grant
    Filed: August 6, 1993
    Date of Patent: October 7, 1997
    Assignee: Boehringer Mannheim GmbH
    Inventors: Christoph Seidel, Ursula-Henrike Wienhues, Hubert Bayer, Guenther-Gerhard Jung, Hans Georg Ihlenfeldt
  • Patent number: 5486476
    Abstract: The invention concerns peptides which have a partial sequence of lipoprotein (a) as well as their use for the purification of antibodies by means of affinity chromatography, as an immunogen for the production of antibodies and as a standard in an immunological test or as a competitive hapten in an agglutination test.
    Type: Grant
    Filed: February 9, 1994
    Date of Patent: January 23, 1996
    Assignee: Boehringer Mannheim GmbH
    Inventors: Geoffrey Burns, Wolf-Deiter Engel, Christoph Seidel
  • Patent number: 5445820
    Abstract: SLO peptide antigens are described. These peptide antigens are suitable for the determination of SLO antibodies, as immunogens for the production of antibodies against SLO.
    Type: Grant
    Filed: November 29, 1993
    Date of Patent: August 29, 1995
    Assignee: Boehringer Mannheim GmbH
    Inventors: Christoph Seidel, Geoffrey Burns, Wolf-Dieter Engel